Finance

Beta
Lists
4164:TADAWUL
Al Nahdi Medical Company SJSC
SAR 95.80
-0.67%
(-0.65) 1D
Jun 7, 3:19:31 PM GMT+3  ·   SAR
All symbols
SymbolPriceChange% Change
Generating top insights for 4164...
Open
SAR 96.45
High
SAR 96.70
Low
SAR 95.10
Mkt. cap
12.45B
Avg. vol.
116.60K
Volume
89.78K
Dividend
5.85%
Quarterly dividend
SAR 1.40
Ex-dividend date
Mar 30, 2026
P/E ratio
15.35
52-wk high
SAR 132.10
52-wk low
SAR 91.00
EPS
SAR 6.24
Shares outstanding
80.35M
No. of employees
6K
Open
SAR 96.45
High
SAR 96.70
Low
SAR 95.10
Mkt. cap
12.45B
Avg. vol.
116.60K
Volume
89.78K
Dividend
5.85%
Quarterly dividend
SAR 1.40
Ex-dividend date
Mar 30, 2026
P/E ratio
15.35
52-wk high
SAR 132.10
52-wk low
SAR 91.00
EPS
SAR 6.24
Shares outstanding
80.35M
No. of employees
6K
News stories
From sources across the web
About Al Nahdi Medical Company SJSC
CEO-
Employees6.15K
Founded1986
Headquarters-
SectorDrug
Websitenahdi.sa
Previous reportsAll values in SAR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SAR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.53B
2.46B
2.59B
2.79B
Cost of goods sold
1.56B
1.52B
1.75B
1.81B
Cost of revenue
1.56B
1.52B
1.75B
1.81B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
718.00M
756.61M
630.42M
734.17M
Operating expense
705.31M
753.00M
633.76M
727.99M
Total operating expenses
2.27B
2.27B
2.38B
2.53B
Operating income
260.64M
187.57M
207.85M
259.74M
Other non operating income
74.00
63.00
-52.76M
210.15K
EBT including unusual items
238.37M
166.46M
188.39M
239.22M
EBT excluding unusual items
238.37M
166.46M
187.90M
239.00M
Income tax expense
-37.50K
5.21M
12.47M
3.54M
Effective tax rate
-0.02%
3.13%
6.62%
1.48%
Other operating expenses
-12.68M
-3.61M
3.34M
-6.18M
Net income
238.40M
161.25M
175.92M
235.68M
Net profit margin
9.43%
6.55%
6.79%
8.43%
Earnings per share
-
-
-
-
Interest and investment income
15.07M
16.28M
22.55M
14.37M
Interest expense
-37.35M
-37.39M
-1.12M
-35.32M
Net interest expenses
-22.28M
-21.11M
21.44M
-20.95M
Depreciation and amortization charges
-
-
-
-
EBITDA
323.91M
261.10M
282.78M
342.37M
Gain or loss from assets sale
-
-74.66K
-411.45K
-60.72K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer